Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1068 to 1117 of 6456 in total 
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
534\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
535\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerases i, ii, and iii 17.1 kda polypeptide (ec 2.7.7.6) (rpb17) (rpb8) (rpabc3). [source:swissprot;acc:p52434]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
236.662\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
252.708\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0678\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, fetal (myosin heavy chain iib) (myhc-iib). [source:swissprot;acc:q9y623]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
112\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
126\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
536\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lupus la protein (sjogren syndrome type b antigen) (ss-b) (la ribonucleoprotein) (la autoantigen). [source:swissprot;acc:p05455]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
242.531\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
227.136\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06778\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, perinatal (myhc-perinatal). [source:swissprot;acc:p13535]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
112\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
126\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
14\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
537\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative pre-mrna splicing factor rna helicase (deah box protein 15) (atp-dependent rna helicase #46). [source:swissprot;acc:o43143]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.803\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.301\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06736\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
538\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 7.6 kda polypeptide (ec 2.7.7.6) (rpb10) (rpb7.6) (rpabc5). [source:swissprot;acc:p52436]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
237.627\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
253.604\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06724\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
44\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
14\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
539\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, adult 2 (myosin heavy chain iia) (myhc-iia). [source:swissprot;acc:q9ukx2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
112\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
126\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein cgi-27 (c21orf19-like protein). [source:swissprot;acc:q9y316]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
236.964\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
252.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06708\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
540\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
selenide,water dikinase 2 (ec 2.7.9.3) (selenophosphate synthetase 2) (selenium donor protein 2). [source:swissprot;acc:q99611]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
222.156\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
208.201\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.06703\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
541\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
flavoprotein oxidoreductase mical2. [source:refseq;acc:nm\_014632]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, fast skeletal muscle, embryonic (muscle embryonic myosin heavy chain) (smhce). [source:swissprot;acc:p11055]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
112\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
126\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
542\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type ii, 105kd; inositol polyphosphate 4-phosphatase ii; 4-phosphatase ii. [source:refseq;acc:nm\_003866]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06703\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, adult 1 (myosin heavy chain iix/d) (myhc-iix/d). [source:swissprot;acc:p12882]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
112\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
126\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
14\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
543\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, cardiac muscle beta isoform (myhc-beta). [source:swissprot;acc:p12883]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
selenide,water dikinase 1 (ec 2.7.9.3) (selenophosphate synthetase 1) (selenium donor protein 1). [source:swissprot;acc:p49903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06703\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
544\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj756n5.1.1 (continues in em:al133324 as dj1161h23.3) (fragment). [source:sptrembl;acc:q9h430]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
112\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
126\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type 1 isoform b; inositol polyphosphate-4-phosphatase, type i, 107kd; 4-phosphatase i; inositol polyphosphate-4-phosphatase i. [source:refseq;acc:nm\_001566]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06703\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
545\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 6 (eif-6) (b4 integrin interactor) (cab) (p27(bbp)) (b(2)gcn homolog). [source:swissprot;acc:p56537]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
248.866\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
233.287\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06678\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
44\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
14\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
546\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, extraocular (myhc-eo). [source:swissprot;acc:q9ukx3]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
112\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
126\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein (wasp). [source:swissprot;acc:p42768]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.222\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.262\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06671\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
547\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alanyl-trna synthetase (ec 6.1.1.7) (alanine--trna ligase) (alars). [source:swissprot;acc:p49588]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
234.106\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
248.104\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13.998\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene c-crk (p38) (adapter molecule crk). [source:swissprot;acc:p46108]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.346\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06645\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
548\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
selenide,water dikinase 2 (ec 2.7.9.3) (selenophosphate synthetase 2) (selenium donor protein 2). [source:swissprot;acc:q99611]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13.955\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase abl2 (ec 2.7.1.112) (tyrosine kinase arg). [source:swissprot;acc:p42684]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.346\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06645\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
549\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
flavoprotein oxidoreductase mical2. [source:refseq;acc:nm\_014632]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13.955\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.346\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06645\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
550\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type ii, 105kd; inositol polyphosphate 4-phosphatase ii; 4-phosphatase ii. [source:refseq;acc:nm\_003866]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13.955\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase hck (ec 2.7.1.112) (p59-hck/p60-hck) (hemopoietic cell kinase). [source:swissprot;acc:p08631]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.346\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.06645\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
551\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
grb2-related adaptor protein 2 (gads protein) (growth factor receptor binding protein) (grblg) (grf40 adaptor protein) (grf-40) (grb-2-like protein) (grb2l) (grbx) (p38) (hematopoietic cell-associated adaptor protein grpl) (adapter protein grid) (sh3-sh2-sh3 adaptor mona). [source:swissprot;acc:o75791]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
207.261\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.347\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
selenide,water dikinase 1 (ec 2.7.9.3) (selenophosphate synthetase 1) (selenium donor protein 1). [source:swissprot;acc:p49903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13.955\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
552\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
crk-like protein. [source:swissprot;acc:p46109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.346\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06645\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type 1 isoform b; inositol polyphosphate-4-phosphatase, type i, 107kd; 4-phosphatase i; inositol polyphosphate-4-phosphatase i. [source:refseq;acc:nm\_001566]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13.955\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
553\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase abl1 (ec 2.7.1.112) (p150) (c-abl). [source:swissprot;acc:p00519]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.346\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06645\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative pre-mrna splicing factor rna helicase (atp-dependent rna helicase #3) (deah-box protein 16). [source:swissprot;acc:o60231]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13.92\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
554\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fyn (ec 2.7.1.112) (p59-fyn) (syn) (slk). [source:swissprot;acc:p06241]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.346\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06645\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t54 protein. [source:swissprot;acc:q92917]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13.92\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
555\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cbf1 interacting corepressor. [source:refseq;acc:nm\_004882]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
227.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.945\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13.915\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fgr (ec 2.7.1.112) (p55-fgr) (c-fgr). [source:swissprot;acc:p09769]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.346\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06645\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
556\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat displacement protein (cdp) (cut-like 1). [source:swissprot;acc:p39880]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
207.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.368\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06638\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
evolutionarily conserved g-patch domain containing. [source:refseq;acc:nm\_018025]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.945\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13.915\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
557\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein cux-2 (cut-like 2) (fragment). [source:swissprot;acc:o14529]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.272\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.371\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06637\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
shwachman-bodian-diamond syndrome protein (cgi-97). [source:swissprot;acc:q9y3a5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.557\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
230.362\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13.805\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
558\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tgf beta-inducible nuclear protein 1; hairy cell leukemia protein 1. [source:refseq;acc:nm\_014886]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
248.994\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.255\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13.739\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin activating enzyme e1-like protein. [source:refseq;acc:nm\_006395]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
135.087\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
144.041\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06628\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\parbox{\wcA}{\vspace{3pt}\noindent
559\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neural wiskott-aldrich syndrome protein (n-wasp). [source:swissprot;acc:o00401]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
207.309\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.452\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.06612\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/